Ther adv respir dis impact factor
Webb29 jan. 2024 · Information for Journal of Intensive Care Medicine Impact Factor: 2.889 5-Year Impact Factor: 2.947 JOURNAL HOMEPAGE SUBMIT PAPER Restricted access Research article First published online January 29, 2024 Effect of Nurse-Led Goal-Directed Lung Physical Therapy on the Prognosis of Pneumonia in Sepsis Patients in the ICU: A … WebbTHER ADV RESPIR DIS 润色咨询 Therapeutic Advances in Respiratory Disease 出版年份:暂无数据 年文章数:66 投稿命中率:50.0% 出版周期:Bimonthly 自引率:0.7% 审 …
Ther adv respir dis impact factor
Did you know?
WebbResults: A total of 605 patients were included in the study; the mean age (SD) was 68 years (9.1) and mostly were male (80.8%). The mean post-bronchodilator FEV 1 % was 53.4% (19.2%), and the mean BODEx (body mass index, airway obstruction, dyspnea, exacerbation) score was 3.2 (2.0). WebbVM Media Group sp. z o.o., Grupa Via Medica ul. Świętokrzyska 73, 80–180 Gdańsk, Poland phone: +48 58 320 94 94, fax: +48 58 320 94 60,
Webb4 apr. 2024 · Therapeutic Advances in Respiratory Disease Impact Factor: 5.158 5-Year Impact Factor: 4.950 JOURNAL HOMEPAGE SUBMIT PAPER Therapeutic Advances in … WebbUnderstanding the relative and absolute risks related to these factors may be useful for clinicians in evaluating the benefit: risk ratio of various treatment decisions for individual …
WebbDetails for "Ther Adv Respir Dis" Full Journal Title(s) Therapeutic advances in respiratory disease; Journal Field(s) ... [Cites (No-Self) Cumulative %]; the percentage of citations … WebbTher Adv Respir Dis. 2009;3(4):1–11. 11. Calle Rubio M, Casamor R, Miravitlles M. Identification and distribution of COPD phenotypes in clinical practice according to …
WebbAdvanced Search User Guide Journal List; Ther Adv Infect Dis; Journal List; Ther Adv Infect Dis; Therapeutic Advances in Infectious Disease Vols. 1 to 10; 2013 to 2024; Vol. 10 …
WebbThe latest impact score (IS) of the Therapeutic Advances in Respiratory Disease is 4.74. It is computed in the year 2024 as per its definition and based on Scopus data. It is … shanks and buggyWebbTher Adv Respir Dis 2024, Vol. 13: 1–28 DOI: 10.1177/ 1753466619884532 ... Asthma and chronic obstructive pulmonary dis-ease (COPD) are serious public health concerns … shanks and hauser houstonWebb期刊名称. THER ADV RESPIR DIS/Therapeutic Advances in Respiratory Disease. ISSN. 1753-4658. 影响指数话题. 影响指数话题. 预警等级. MedSci期刊指数. 4.423 (MedSci实 … shanks and hauser lawWebb11 apr. 2024 · Therapeutic Advances in Respiratory Disease杂志网站提供THER ADV RESPIR DIS期刊影响因子、JCR和中科院分区查询,SCI期刊投稿经验,Impact … shanks and hauser llpWebbAdvances in Therapy Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 0741-238X. Journal ... Enter journal title, issn or abbr in this box to search. … polymers combined scienceWebbDissanayake S, Suggett J. A review of the in vitro and in vivo valved holding chamber (VHC) literature with a focus on the AeroChamber Plus Flow-Vu Anti-static VHC. Ther Adv … polymer science - series bWebbSince the introduction of CPFE as a clinical syndrome by Cottin et al in 2005, there has been an ongoing evaluation of the impact of emphysema in the natural history of pulmonary fibrosis. 7, 8 The need for future studies to determine the etiology, morbidity, mortality and novel therapeutics for CPFE either with or without PH, has been … shanks and luffy 4k wallpaper